Revenue: The sum of all revenue fields included for a company's operating activities.
TScan Therapeutics, Inc. (TCRX) had Revenue of $2.82M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$2.82M |
$-127.50M |
|
-- |
|
$2.82M |
|
$137.64M |
|
$-134.82M |
|
$7.32M |
|
$-127.50M |
|
$-127.50M |
|
$-127.50M |
|
$-127.50M |
|
$-127.50M |
|
$-127.50M |
|
$-134.82M |
|
$-130.71M |
|
111.99M |
|
111.99M |
|
$-1.14 |
|
$-1.14 |
|
| Balance Sheet Financials | |
$292.72M |
|
$7.24M |
|
$78.40M |
|
$371.12M |
|
$35.96M |
|
$32.07M |
|
$94.19M |
|
$130.15M |
|
$240.97M |
|
$240.97M |
|
$240.97M |
|
56.59M |
|
| Cash Flow Statement Financials | |
$-110.82M |
|
$-52.61M |
|
$208.76M |
|
$138.39M |
|
$183.72M |
|
$45.33M |
|
$9.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.14 |
|
-- |
|
-- |
|
0.12 |
|
0.13 |
|
100.00% |
|
-4787.68% |
|
-4787.68% |
|
-4641.80% |
|
-4527.66% |
|
-4527.66% |
|
$-114.65M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-52.91% |
|
-52.91% |
|
-34.36% |
|
-46.70% |
|
$4.26 |
|
$-1.02 |
|
$-0.99 |
|